Canaan XI L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Tyra Biosciences, Inc. COMMON STOCK, $0.0001 PAR VALUE PER SHARE (TYRA)

Filing Manager
Canaan XI L.P.
Reporting Manager
Canaan XI L.P.
Security
Tyra Biosciences, Inc. COMMON STOCK, $0.0001 PAR VALUE PER SHARE
Symbol
TYRA
Shares outstanding
53,280,800 shares
Disclosed Ownership
2,930,444 shares
Ownership
5.5%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2026, 16:15:02 UTC
Date of event
31 Dec 2025
Previous filing
21 Jan 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Canaan XI L.P. disclosed 5.5% ownership in Tyra Biosciences, Inc. COMMON STOCK, $0.0001 PAR VALUE PER SHARE (TYRA) on 31 Dec 2025."

Quick Takeaways

  • Canaan XI L.P. filed SCHEDULE 13G/A for Tyra Biosciences, Inc. COMMON STOCK, $0.0001 PAR VALUE PER SHARE (TYRA).
  • Disclosed ownership: 5.5%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 21 Jan 2025.
  • Current filing was accepted on 13 Feb 2026, 16:15.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Canaan XI L.P. 5.5% 2,930,444 2,930,444 0 /s/ Nancy Levenson Nancy Levenson, Attorney-in-Fact
Canaan Partners XI LLC 5.5% 2,930,444 2,930,444 0 /s/ Nancy Levenson Nancy Levenson, Attorney-in-Fact
Canaan 2020+ Co-Investment L.P. - Series 7 0.8% 443,885 443,885 0 /s/ Nancy Levenson Nancy Levenson, Attorney-in-Fact
Canaan Partners 2020+ Co-Investment LLC 0.8% 443,885 443,885 0 /s/ Nancy Levenson Nancy Levenson, Attorney-in-Fact

Sponsored